Provided by Tiger Trade Technology Pte. Ltd.

Biomerica

2.11
+0.06002.93%
Volume:6.18K
Turnover:13.09K
Market Cap:6.37M
PE:-1.37
High:2.12
Open:2.11
Low:2.10
Close:2.05
52wk High:4.88
52wk Low:1.87
Shares:3.02M
Float Shares:2.94M
Volume Ratio:0.39
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5351
EPS(LYR):-2.1649
ROE:-84.30%
ROA:-49.43%
PB:1.44
PE(LYR):-0.97

Loading ...

Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Dow Jones
·
Jan 15

BRIEF-Biomerica Announces CMS Medicare Payment Rate Of $300 For Revolutionary Infoods® IBS Test

Reuters
·
Dec 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary Infoods® Ibs Test

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc - $300 Rate Applies to Medicare Claims From January 2026

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 16, 2025

Egyptian Drug Authority Approves Biomerica's Full Portfolio of Rapid Screening Tests

Reuters
·
Dec 11, 2025

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

GlobeNewswire
·
Nov 25, 2025

BRIEF-Biomerica Expands Contract Development And Manufacturing Services To Meet Growing Market Demand

Reuters
·
Nov 06, 2025

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

GlobeNewswire
·
Nov 06, 2025

Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US

MT Newswires Live
·
Oct 16, 2025

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

GlobeNewswire
·
Oct 16, 2025

Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Reuters
·
Oct 15, 2025

Press Release: Biomerica Reports First Quarter Fiscal 2026 Financial Results

Dow Jones
·
Oct 15, 2025

Biomerica Q1 Sales $1.380M Down From $1.807M YoY

Benzinga
·
Oct 15, 2025

Biomerica Inc announces date for annual meeting of stockholders

Reuters
·
Oct 10, 2025

Press Release: Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Dow Jones
·
Oct 08, 2025

Biomerica Inc. Files Amendment to 2025 Annual Report

Reuters
·
Sep 27, 2025